Cutler Group LP Galmed Pharmaceuticals Ltd. Call Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Oct 26, 2021	SELL	$2.41 - $3.33 $3,856 - $5,328	-1,600 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$2.24 - $3.9 $2,016 - $3,510	900 Added 128.57%	1,600 $0
Q1 2021 Apr 26, 2021	SELL	$3.19 - $5.4 $319 - $540	-100 Reduced 12.5%	700 $0
Q4 2020 Jan 21, 2021	BUY	$3.06 - $4.17 $918 - $1,251	300 Added 60.0%	800 $0
Q3 2020 Oct 27, 2020	SELL	$3.46 - $5.69 $692 - $1,138	-200 Reduced 28.57%	500 $0
Q2 2020 Jul 22, 2020	SELL	$3.22 - $6.08 $16,100 - $30,400	-5,000 Reduced 87.72%	700 $0
Q1 2020 May 07, 2020	BUY	$3.3 - $6.84 $5,610 - $11,628	1,700 Added 42.5%	5,700 $1,000
Q4 2019 Feb 06, 2020	BUY	$3.61 - $6.75 $9,747 - $18,225	2,700 Added 207.69%	4,000 $3,000
Q4 2018 Feb 05, 2019	BUY	$6.59 - $14.47 $5,272 - $11,576	800 Added 160.0%	1,300 $0
Q3 2018 Nov 07, 2018	BUY	$10.55 - $15.28 $5,275 - $7,640	500 New	500 $0

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $122M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.